
Gala evening of the Institute
Don't miss the annual gala evening of the de Duve Institute, on September 10.
News
To understand the mechanisms underlying this pancreatic phenotype, Memoona Rajput, co-first author of the study, developed and analyzed new mouse models carrying patient-derived Nphp3 mutations or a conditional deletion of Nphp3 specifically in pancreatic ductal cells. These models displayed progressive acinar atrophy and adipopancreatosis. The study also revealed several previously unrecognized structural abnormalities in the pancreas of Nphp3 mutant mice. Similar abnormalities were observed in other mouse models of ciliary dysfunction, suggesting that they may represent a common feature of ciliogenic pancreatic disease.
The researchers further found that the adipocytes accumulating in the pancreas displayed a molecular profile similar to that of white adipocytes and may arise from resident mesothelial-derived fibroblasts. Based on these findings in mouse models, the researchers then investigated whether a similar pancreatic phenotype could be detected in patients carrying HNF1B or NPHP3 mutations. Using non-invasive Dixon-MRI, they measured pancreatic fat content in patients and matched healthy controls. They found significantly higher pancreatic fat content in patients with HNF1B or NPHP3 mutations, supporting the presence of adipopancreatosis in these patients and providing evidence that the pancreatic phenotype identified in mice also occurs in humans.
Together, these results establish the pancreas as a clinically relevant target of ciliopathies and expand the known spectrum of HNF1B- and NPHP3-related diseases to include exocrine pancreatic dysfunction. These findings have important clinical implications. Patients carrying mutations in HNF1B, NPHP3, and potentially other ciliopathy-associated genes may benefit from evaluation of pancreatic structure and exocrine function, particularly when unexplained gastrointestinal symptoms are present. Early detection may be particularly important in patients with kidney disease, as exocrine pancreatic insufficiency can lead to nutritional complications and may further compromise renal function through increased intestinal oxalate absorption. Further studies will be needed to determine how frequent ciliogenic pancreatopathy is across different ciliopathies and whether early intervention or therapies targeting ciliary function could prevent or reverse pancreatic damage.
Article describing this research
Ciliogenic pancreatopathy reveals a link between ciliopathies and exocrine pancreatic disease
Rajput M, Flasse L, Porée E, Pointeau O, Serafin A, Papadopoulos N, Achouri Y, Moro J, Loriot A, Wilsch-Brauninger M, Gillion V, Godefroid N, Bodson C, Lopez Muneta L, Depestel C, Morel M, Cordi S, Garcia de Herreros A, Haumaitre C, Lemaigre F, Rovira M, Viau A, Grapin-Botton A, Saunier S, Jacquemin P, Scheers I
Gut (2026) gutjnl-2025-337224
In the press
UCLouvain.be - Découverte d’une nouvelle maladie pancréatique - 24/09/2026
CourrierDeBruxelles.be - Découverte d'une nouvelle maladie pancréatique liée à des troubles génétiques rares - 24/09/2026
LeSpecialiste.be - Une nouvelle atteinte pancréatique mise au jour dans les ciliopathies - 24/09/2026
MediQuality.net - Une nouvelle maladie pancréatique liée aux ciliopathies : Saint-Luc et l'UCLouvain bousculent les certitudes - 24/09/2026
LeJournalDuMédecin.be - Les ciliopathies peuvent également toucher le pancréas (UCLouvain) - 24/09/2026
DeSpecialist.eu - Nieuwe pancreasaantasting ontdekt bij ciliopathieën - 24/09/2026
MediQuality.net - Een nieuwe alvleesklieraandoening in verband met ciliopathieën: Saint-Luc en de UCLouvain zetten de gangbare opvattingen op hun kop - 24/09/2026
Artsenkrant.be - Ciliopathieën kunnen pancreas aantasten (UCLouvain) - 24/09/2026
Also in Medi-Sphere.be and Medi-Sfeer.be